Novocure
NVCR
10.71
+0.02
+0.19%
Novocure
US · NVCR
#2889 by market cap
Listed 2015
10.71
+0.02
+0.19%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 19 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.4 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 89.17% -2.41pp
- Institutions
- 291 +19
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund59.73%
Hedge Fund15.93%
Public Company9.06%
Individual/Insider8.66%
Private Company1.66%
Government Pension Fund1.60%
Insurance Company0.94%
VC/PE Fund0.12%
Family Office/Trust0.12%
Other2.18%
Top holders as of 2026-09-30
FMR
14.86% · 17.38M sh
BlackRock
10.15% · 11.86M sh
Soleus Capital Management, L.P.
8.06% · 9.43M sh
Hansjoerg Wyss
6.96% · 8.14M sh
Vanguard Portfolio Management, LLC
5.55% · 6.49M sh
Vanguard Capital Management, LLC
4.21% · 4.92M sh
Morgan Stanley
4.02% · 4.70M sh
State Street Global Advisors
2.50% · 2.93M sh
Geode Capital Management, LLC
2.40% · 2.81M sh
Wells Fargo & Company
2.16% · 2.53M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 31 buys · 19 sells
| Name | Role | Stake |
|---|---|---|
| Hansjoerg Wyss | Former Director | 6.96% |
| William Doyle | Executive Chairperson | 0.46% |
| Asaf Danziger | Director | 0.19% |
| William Vernon | Lead Independent Director | 0.17% |
| Uri Weinberg | Chief Innovation Officer & Chief Medical Officer | 0.13% |
| Frank Leonard | Chief Executive Officer | 0.13% |
| Ashley Cordova | Former Chief Executive Officer | 0.11% |
| Barak Ben-Arye | General Counsel | 0.11% |
| Michael Puri | Chief Human Resources Officer | 0.09% |
| Kinyip Leung | Independent Director | 0.08% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-08 | Christoph Brackmann | Chief Financial Officer | Open Market Disposition | -7,343 | $12.86 |
| 2026-11-08 | Mukund Paravasthu | Chief Operating Officer | Open Market Disposition | -3,079 | $12.86 |
| 2026-11-01 | Michael Puri | Chief Human Resources Officer | Open Market Disposition | -660 | $13.24 |
| 2026-06-29 | Asaf Danziger | Director | Other Acquisition | +268 | $11.15 |
| 2026-06-29 | Frank Leonard | Chief Executive Officer | Other Acquisition | +1,905 | $11.15 |
| 2026-06-29 | Michael Puri | Chief Human Resources Officer | Other Acquisition | +1,905 | $11.15 |
| 2026-06-29 | Barak Ben-Arye | General Counsel | Other Acquisition | +1,299 | $11.15 |
| 2026-06-03 | Frank Leonard | Chief Executive Officer | Open Market Disposition | -34,273 | $17.93 |
| 2026-06-02 | Jeryl Hilleman | Independent Director | Other Acquisition | +11,610 | -- |
| 2026-06-02 | Jeryl Hilleman | Independent Director | Other Derivative Acquisition | +16,999 | $16.15 |
| 2026-06-02 | David Hung | Independent Director | Other Acquisition | +11,610 | -- |
| 2026-06-02 | David Hung | Independent Director | Other Derivative Acquisition | +16,999 | $16.15 |
| 2026-06-02 | Timothy Scannell | Former Independent Director | Other Acquisition | +11,610 | -- |
| 2026-06-02 | Timothy Scannell | Former Independent Director | Other Derivative Acquisition | +16,999 | $16.15 |
| 2026-06-02 | Kinyip Leung | Independent Director | Other Acquisition | +11,610 | -- |
| 2026-06-02 | Kinyip Leung | Independent Director | Other Derivative Acquisition | +16,999 | $16.15 |
| 2026-06-02 | William Vernon | Lead Independent Director | Other Acquisition | +11,610 | -- |
| 2026-06-02 | William Vernon | Lead Independent Director | Other Derivative Acquisition | +16,999 | $16.15 |
| 2026-06-02 | Martin Madden | Independent Director | Other Acquisition | +11,610 | -- |
| 2026-06-02 | Martin Madden | Independent Director | Other Derivative Acquisition | +16,999 | $16.15 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Novocure discussion 0 comments